Trial intelligence / Profile preview

Rimonabant for Maintenance of Smoking Cessation (STRATUS-WW)

NCT00459173Phase 3Completed

Sponsor
Sanofi
Start
Nov 2002
Primary completion
Sep 2005
Countries
3
01

Overview

A Phase 3 trial of rimonabant in nicotine dependence, sponsored by Sanofi. Started Nov 2002; status: completed.

02

Drugs

rimonabant
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT00459173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00459173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call